Y. Boutsen

1.6k total citations
40 papers, 1.2k citations indexed

About

Y. Boutsen is a scholar working on Orthopedics and Sports Medicine, Oncology and Rheumatology. According to data from OpenAlex, Y. Boutsen has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Orthopedics and Sports Medicine, 12 papers in Oncology and 9 papers in Rheumatology. Recurrent topics in Y. Boutsen's work include Bone health and osteoporosis research (14 papers), Bone health and treatments (12 papers) and Bone Metabolism and Diseases (7 papers). Y. Boutsen is often cited by papers focused on Bone health and osteoporosis research (14 papers), Bone health and treatments (12 papers) and Bone Metabolism and Diseases (7 papers). Y. Boutsen collaborates with scholars based in Belgium, Netherlands and France. Y. Boutsen's co-authors include Jean‐Pierre Devogelaer, J.-P. Devogelaer, Stefan Goemaere, W. Esselinckx, Serge Rozenberg, Jacques Jamart, Jean‐Marc Kaufman, Steven Boonen, Jean‐Yves Reginster and P. Bergmann and has published in prestigious journals such as Journal of Bone and Mineral Research, Bone and Osteoporosis International.

In The Last Decade

Y. Boutsen

37 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Boutsen Belgium 16 698 485 329 201 158 40 1.2k
George Trovas Greece 20 619 0.9× 330 0.7× 251 0.8× 228 1.1× 162 1.0× 54 1.2k
F. Zucchi Italy 12 273 0.4× 166 0.3× 119 0.4× 124 0.6× 195 1.2× 21 740
L. Binelli Italy 13 342 0.5× 143 0.3× 92 0.3× 126 0.6× 166 1.1× 16 708
D. T. Baran United States 21 699 1.0× 161 0.3× 276 0.8× 322 1.6× 283 1.8× 40 1.4k
Elisabeth Zwettler Austria 16 336 0.5× 182 0.4× 166 0.5× 361 1.8× 39 0.2× 28 758
P. Schneider Germany 20 408 0.6× 118 0.2× 118 0.4× 306 1.5× 86 0.5× 44 983
Kichizo Yamamoto Japan 21 596 0.9× 291 0.6× 204 0.6× 537 2.7× 49 0.3× 55 1.1k
Charles-Joël Menkès France 12 351 0.5× 328 0.7× 181 0.6× 123 0.6× 57 0.4× 41 824
Paula Dakin United States 9 613 0.9× 561 1.2× 378 1.1× 142 0.7× 70 0.4× 34 970
S. Gonnelli Italy 13 414 0.6× 236 0.5× 206 0.6× 112 0.6× 108 0.7× 18 738

Countries citing papers authored by Y. Boutsen

Since Specialization
Citations

This map shows the geographic impact of Y. Boutsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Boutsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Boutsen more than expected).

Fields of papers citing papers by Y. Boutsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Boutsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Boutsen. The network helps show where Y. Boutsen may publish in the future.

Co-authorship network of co-authors of Y. Boutsen

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Boutsen. A scholar is included among the top collaborators of Y. Boutsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Boutsen. Y. Boutsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boutsen, Y., et al.. (2024). Dramatic response of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome to tofacitinib monotherapy: a case report. Journal of Medical Case Reports. 18(1). 57–57. 2 indexed citations
2.
Durez, Patrick, Pedro C. Miranda, Antoaneta A. Toncheva, et al.. (2012). Active Immunization with TNF-Kinoid in Rheumatoid Arthritis Patients with Secondary Resistance to Tumor Necrosis Factor-Alpha Antagonists Is Safe and Immunogenic. Arthritis & Rheumatism.
3.
Devogelaer, Jean‐Pierre, Y. Boutsen, Damien Gruson, & Daniel Manicourt. (2011). Is There a Place for Bone Turnover Markers in the Assessment of Osteoporosis and its Treatment?. Rheumatic Disease Clinics of North America. 37(3). 365–386. 16 indexed citations
4.
Bergmann, P., J.J. Body, Steven Boonen, et al.. (2008). Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club. International Journal of Clinical Practice. 63(1). 19–26. 114 indexed citations
5.
Body, J.J., Pierre Bergmann, S. Boonen, et al.. (2007). Management of cancer treatment-induced bone loss in early breast and prostate cancer - a consensus paper of the Belgian Bone Club. Osteoporosis International. 18(11). 1439–1450. 82 indexed citations
6.
Devogelaer, Jean‐Pierre, Stefan Goemaere, Steven Boonen, et al.. (2005). Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club. Osteoporosis International. 17(1). 8–19. 106 indexed citations
7.
Boonen, Steven, Jean‐Jacques Body, Y. Boutsen, et al.. (2005). Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporosis International. 16(3). 239–254. 56 indexed citations
8.
Manicourt, D., et al.. (2004). Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity. Arthritis & Rheumatism. 50(11). 3690–3697. 113 indexed citations
9.
Maiter, Dominique, et al.. (2000). Evaluation de la substitution par corticostéroïdes et de ses répercussions osseuses dans la maladie d'Addison.. Annales d Endocrinologie. 61(3). 179–183. 5 indexed citations
10.
Maiter, Dominique, et al.. (2000). [Evaluation of glucocorticoid replacement therapy and of their effects on bone mineral density in Addison's disease]. Annales d Endocrinologie. 61(3). 179–183. 2 indexed citations
11.
Boutsen, Y., et al.. (2000). Cervical epidural pseudotumor and multifocal fibrosclerosis. Journal of Neurosurgery Spine. 93(1). 152–156. 18 indexed citations
12.
Baudrez, V., et al.. (1999). Subacromial-subdeltoid lipoma arborescens associated with a rotator cuff tear. Skeletal Radiology. 28(5). 283–285. 38 indexed citations
14.
Deltombe, Thierry, et al.. (1999). Cervical spinal cord injury in sapho syndrome. Spinal Cord. 37(4). 301–304. 14 indexed citations
15.
Nachega, Jean B., et al.. (1998). Septic arthritis caused by haemophilus influenzae associated with endocarditis. Clinical Rheumatology. 17(4). 340–342. 2 indexed citations
16.
Boutsen, Y., et al.. (1997). Neuroarthropathy of the shoulder of unexpected origin. Clinical Rheumatology. 16(4). 413–416. 5 indexed citations
17.
Boutsen, Y., Jacques Jamart, W. Esselinckx, M. Stoffel, & Jean‐Pierre Devogelaer. (1997). Primary Prevention of Glucocorticoid-Induced Osteoporosis with Intermittent Intravenous Pamidronate: A Randomized Trial. Calcified Tissue International. 61(4). 266–271. 94 indexed citations
18.
Boutsen, Y., J.-P. Devogelaer, Jacques Malghem, Henri Noël, & C Nagant de Deuxchaisnes. (1996). Antacid-induced osteomalacia. Clinical Rheumatology. 15(1). 75–80. 8 indexed citations
19.
Deltombe, Thierry, et al.. (1996). LYME BORRELIOSIS NEUROPATHY. American Journal of Physical Medicine & Rehabilitation. 75(4). 314–316. 4 indexed citations
20.
Boutsen, Y., et al.. (1993). Amyloidose Ureterale Bilaterale Revelee Par Une Anurie. Acta Clinica Belgica. 48(5). 331–337. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026